Last update Aug. 6, 2021

Pyritinol Hydrochloride

Low Risk

Moderately safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

Nootropic used without evidence of efficacy in the treatment of various cerebrovascular and mental diseases and rheumatoid arthritis. Also promoted as a tonic.

At the date of the last update, the authors did not find any published data on its excretion in breast milk.

The scarcity of published pharmacokinetic data does not allow us to predict its possible excretion in breast milk.

Product with very few bibliographic references, marketed in very few countries. Considered a drug of low therapeutic utility (SEFAP 2012, UN 2005, INSALUD 2001).

Until more published data is known about this drug in relation to breastfeeding, known safer alternatives may be preferable, especially during the neonatal period and in the event of prematurity.

Alternatives

We do not have alternatives for Pyritinol Hydrochloride.

Suggestions made at e-lactancia are done by APILAM team, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Pyritinol Hydrochloride in other languages or writings:

Group

Pyritinol Hydrochloride belongs to this group or family:

Tradenames

Main tradenames from several countries containing Pyritinol Hydrochloride in its composition:

Pharmacokinetics

Variable Value Unit
Molecular weight 459 daltons

References

  1. SEFAP. Sociedad Española de Farmacéuticos de Atención Primaria. Propuesta de medicamentos a desfinanciar por el Sistema Nacional de Salud. 2012 Full text (in our servers)
  2. ONU. United Nations Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or not Approved by Governments. Twelfth issue. 2005 Full text (link to original source) Full text (in our servers)
  3. INSALUD. Área de Gestión de Farmacia. Subdirección General de Atención Primaria. Instituto Nacional de la Salud. Utilidad terapéutica de los medicamentos financiados por el Sistema Nacional de Salud. 2001 Full text (in our servers)

Total visits

4,854

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by IHAN of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM